A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

NCT07239466 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Radiotherapy
Immunotherapy
Chemotherapy

Interventions

RADIATION: Short-course radiotherapy
DRUG: Capecitabine
DRUG: Oxaliplatin
PROCEDURE: TME surgery
DIETARY_SUPPLEMENT: β-hydroxybutyrate

Sponsor

Tao Zhang